BIXIO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 1.433
EU - Europa 1.275
AS - Asia 1.076
SA - Sud America 199
AF - Africa 53
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.042
Nazione #
US - Stati Uniti d'America 1.380
RU - Federazione Russa 748
SG - Singapore 503
CN - Cina 188
BR - Brasile 159
IT - Italia 158
VN - Vietnam 121
HK - Hong Kong 109
DE - Germania 77
FR - Francia 54
GB - Regno Unito 52
SE - Svezia 41
IN - India 38
IE - Irlanda 35
FI - Finlandia 30
CA - Canada 29
KR - Corea 27
TR - Turchia 20
JP - Giappone 19
MX - Messico 18
PL - Polonia 17
AR - Argentina 13
ES - Italia 13
NL - Olanda 13
AT - Austria 11
BJ - Benin 11
TG - Togo 11
NG - Nigeria 9
BD - Bangladesh 7
ID - Indonesia 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
CO - Colombia 5
EG - Egitto 5
IQ - Iraq 5
PE - Perù 5
PK - Pakistan 5
UA - Ucraina 5
BO - Bolivia 4
EC - Ecuador 4
KE - Kenya 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
JM - Giamaica 3
LT - Lituania 3
NZ - Nuova Zelanda 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
CH - Svizzera 2
GE - Georgia 2
GR - Grecia 2
PH - Filippine 2
PY - Paraguay 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AU - Australia 1
BE - Belgio 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MK - Macedonia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.042
Città #
Dallas 311
Moscow 307
Singapore 282
Ashburn 209
San Jose 170
Hong Kong 108
Chandler 89
New York 68
Verona 58
Ho Chi Minh City 41
Beijing 38
The Dalles 37
Dublin 35
Los Angeles 34
Hanoi 29
Munich 26
Redmond 23
Redondo Beach 19
Tokyo 18
Orem 16
São Paulo 16
London 15
Montreal 15
Warsaw 15
Denver 14
Falkenstein 13
Turku 13
Buffalo 12
Phoenix 12
Cotonou 11
Helsinki 11
Lomé 11
Milan 11
Santa Clara 11
Brooklyn 10
Stockholm 10
Abuja 9
Rome 9
Amsterdam 8
Chennai 8
Da Nang 8
Frankfurt am Main 8
Lawrence 8
Princeton 8
Belo Horizonte 7
City of London 7
Heidelberg 7
Hyderabad 7
Mexico City 7
Atlanta 6
Boston 6
Council Bluffs 6
Houston 6
Manchester 6
Querétaro 6
San Francisco 6
Seattle 6
Sindelfingen 6
Wilmington 6
Ankara 5
Brasília 5
Chicago 5
Columbus 5
Jacksonville 5
Jinan 5
Lappeenranta 5
Madrid 5
Merkez 5
Rio de Janeiro 5
Santo André 5
Toronto 5
Vienna 5
Bologna 4
Dongguan 4
Guangzhou 4
Hải Dương 4
Johannesburg 4
Lima 4
Mumbai 4
Nairobi 4
New Delhi 4
Parma 4
Riyadh 4
Southend 4
Vicenza 4
Washington 4
Baghdad 3
Baku 3
Boydton 3
Bussolengo 3
Cairo 3
Calgary 3
Can Tho 3
Changsha 3
Charleston 3
Fuzhou 3
Haikou 3
Jakarta 3
La Paz 3
Marseille 3
Totale 2.442
Nome #
Multimodal ultrasonographic muscle assessment in patients with systemic sclerosis and correlations with body composition 209
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 206
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 167
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 161
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 139
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 138
Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission 138
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases 136
Changes in bone turnover markers and bone modulators during abatacept treatment 134
Real-world Coronavirus disease-19 vaccine hesitancy in systemic sclerosis 134
Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review 129
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 128
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 127
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study 124
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 123
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study 121
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis 120
Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options 119
Efficacy and safety of digital nerve block for pain management during sharp debridement of digital ulcers in systemic sclerosis: A prospective observational study 113
Clinical image: ultrasound findings and magnetic resonance imaging comparison in the muscular involvement in polyarteritis nodosa 112
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 111
Ultrasonographic non-radiographic erosions could predict the efficacy of belimumab in articular systemic lupus erythematosus 107
Long-Term Bone Mineral Density Changes in Kidney Transplant Recipients Treated with Denosumab: A Retrospective Study with Nonequivalent Control Group 94
Discontinuation of infliximab leading to auditory loss in a patient with Cogan syndrome: A case report 93
The potential pathogenic role of gut microbiota in rheumatic diseases: a human-centred narrative review 92
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 90
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 89
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 86
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 84
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 84
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 80
Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry 74
ORCHESTRA Delphi Consensus: Diagnostic and Therapeutic Management of SARS-CoV-2 Infection in Rheumatological Patients 67
Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis 41
Ultrasonographic assessment of digital ulcers in systemic sclerosis: Quantitative and qualitative insights for evaluation and follow-up 39
Multimodal ultrasound in the assessment of muscle involvement in systemic sclerosis patients: results from a bicentric study 37
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 34
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study 25
Totale 4.105
Categoria #
all - tutte 13.851
article - articoli 13.292
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 559
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 1 2 6
2021/202285 11 19 3 4 5 0 6 4 4 3 3 23
2022/2023256 12 34 16 37 24 60 4 16 32 8 12 1
2023/2024215 7 9 14 23 26 52 8 10 10 4 33 19
2024/2025701 41 21 38 85 28 21 44 21 104 60 85 153
2025/20262.799 150 185 306 536 750 178 239 166 160 129 0 0
Totale 4.105